Tyler Julie L. 4
4 · ABBOTT LABORATORIES · Filed Feb 22, 2023
Insider Transaction Report
Form 4
Tyler Julie L.
SENIOR VICE PRESIDENT
Transactions
- Tax Payment
Common shares without par value
2023-02-21$106.74/sh−341$36,398→ 41,156 total - Tax Payment
Common shares without par value
2023-02-19$106.74/sh−291$31,061→ 41,497 total - Sale
Common shares without par value
2023-02-22$103.24/sh−260$26,842→ 40,896 total - Award
Common shares without par value
2023-02-17+7,920→ 41,788 total - Award
Option (right to buy)
2023-02-17+31,236→ 31,236 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (31,236 underlying)
Holdings
- 9,513(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,412 on February 17, 2024, 10,412 on February 17, 2025 and 10,412 on February 17, 2026.